cabergoline / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 66 Diseases   17 Trials   17 Trials   1476 News 


«12345678910111213...1617»
  • ||||||||||  Journal:  Panhypopituitarism as the first manifestation of sarcoidosis: case report (Pubmed Central) -  Sep 20, 2022   
    Later, additional examination revealed signs of intrathoracic lymphadenopathy and focal changes in the lung parenchyma on CT, as well as skin lesions. Despite the biochemical compensation of hypopituitarism, the clinical efficacy of hormonal therapy with cabergoline, testosterone, hydrocortisone and levothyroxine sodium was insufficient, and the patient's condition improved after the addition of immunosuppressive and anti-inflammatory therapy with methotrexate and methylprednisolone.
  • ||||||||||  cabergoline / Generic mfg.
    Journal:  Cardiometabolic profile of young women with hypoprolactinemia. (Pubmed Central) -  Sep 20, 2022   
    Despite the biochemical compensation of hypopituitarism, the clinical efficacy of hormonal therapy with cabergoline, testosterone, hydrocortisone and levothyroxine sodium was insufficient, and the patient's condition improved after the addition of immunosuppressive and anti-inflammatory therapy with methotrexate and methylprednisolone. The obtained results suggest that hypoprolactinemia in women of reproductive age may increase cardiometabolic risk.
  • ||||||||||  cabergoline / Generic mfg.
    Journal:  Macroprolactinoma-Induced Syndrome of Inappropriate Antidiuresis and Its Reversal with Dopamine Agonist Therapy. (Pubmed Central) -  Sep 10, 2022   
    The SIAD experienced by the patient corrected rapidly with initiation of cabergoline...There was no recurrence of the tumor, and the patient continued to have normonatremia and normoprolactinemia 7 years after her operation. To my knowledge, this is the first report in the literature of pathology-confirmed macroprolactinoma marked by SIAD that showed rapid normalization of water metabolism with dopamine agonist therapy.
  • ||||||||||  cabergoline / Generic mfg., temozolomide / Generic mfg., bromocriptine / Generic mfg.
    Review, Journal:  Treatment of Prolactinoma. (Pubmed Central) -  Sep 3, 2022   
    DAs remain a reliable mode of therapy for most prolactinomas but results from transsphenoidal surgery in expert hands have improved considerably over the last one to two decades. Surgery should be strongly considered as primary therapy, particularly in the setting of microprolactinomas, non-invasive macroprolactinomas, or prior to attempting pregnancy, and has an important role in the management of DA resistant and aggressive prolactinomas.
  • ||||||||||  cabergoline / Generic mfg.
    Journal:  Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine. (Pubmed Central) -  Aug 31, 2022   
    Inhibition of circulating prolactin occurred with systemic cabergoline, a dopamine D2 receptor agonist, blocked priming selectively in females...This sexually dimorphic mechanism may help to explain female prevalence of migraine. KOR antagonists, currently in phase II clinical trials, may be useful as migraine preventives in both sexes, while dopamine agonists and prolactin/PRLR antibodies may improve therapy for migraine, and other stress-related neurological disorders, in women.
  • ||||||||||  cabergoline / Generic mfg.
    Journal:  Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma. (Pubmed Central) -  Aug 30, 2022   
    91% of men achieved eugonadism within the first year following prolactin normalization. These findings may support informed clinical decision-making regarding the initiation of testosterone replacement in men with macroprolactinomas.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    EXPLORING THE REPRODUCTIVE BLACK MARKET: FERTILITY MEDICATIONS ON THE DARK WEB (Anaheim Convention Center - 208A) -  Aug 21, 2022 - Abstract #ASRM2022ASRM_526;    
    Due to stigma, drug shortages, and high costs patients will continue to resort to illegal means of obtaining fertility medications despite significant risks of using drugs without a prescription (e.g., counterfeit, contamination, and presence of untested substances). IMPACT STATEMENT: Physicians should be aware of the increasing use of illicit online marketplaces to purchase prescription medications as a significant public health issue (e.g., drug misuse/abuse) as well the risks of serious health consequences including death due to substandard or falsified medical products.
  • ||||||||||  cabergoline / Generic mfg., bromocriptine / Generic mfg.
    THE CLINICAL CORRELATION BETWEEN POLYCYSTIC OVARY SYNDROME (PCOS) AND PITUITARY ADENOMA (Anaheim Convention Center - Poster Hall in Expo Hall) -  Aug 21, 2022 - Abstract #ASRM2022ASRM_443;    
    IMPACT STATEMENT: To expect a favorable clinical course for these patients, a systemic diagnosis, treatment and follow-up plan should be established. Therefore, a multidisciplinary approach between neurosurgery and OBGY is essential.
  • ||||||||||  cabergoline / Generic mfg.
    Review, Journal:  Preoperative Medical Treatment for Patients With Acromegaly: Yes or No? (Pubmed Central) -  Aug 17, 2022   
    The aim of this review is to analyze the potential benefits and pitfalls of using presurgical medical treatment in acromegaly in view of the contradictory literature data. We also attempt to determine the profile of patients who might most benefit from this presurgical medical treatment approach as an individualized therapeutic management of acromegaly.
  • ||||||||||  cabergoline / Generic mfg.
    Review, Journal:  Giant Prolactinoma Embedded by Pseudoaneurysm of the Cavernous Carotid Artery Treated with a Tailored Therapeutic Scheme. (Pubmed Central) -  Aug 11, 2022   
    Our multimodal approach with the first-line therapy of low-dose cabergoline to obtain prolactin normalization with minimum risks of aneurysms rupture and subsequent endovascular treatment with flow diverter has not been described elsewhere to our knowledge. In the cases, we suggest adopting a tailored low-dose cabergoline therapy scheme to avoid rupture during cytoreduction and initiate a close neuroradiological follow-up program.
  • ||||||||||  cabergoline / Generic mfg.
    Retrospective data, Review, Journal:  Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis. (Pubmed Central) -  Jul 31, 2022   
    Smaller adenoma size, lower prolactin level, earlier prolactin normalization, and higher testosterone patients were related to testosterone normalization. Effect of CBG to promote tumor shrinkage in NFPAs was low, while prevention of tumor progression after surgery was seen in half of the cases, with a low frequency of adverse events.
  • ||||||||||  cabergoline / Generic mfg.
    Retrospective data, Journal:  Resistant prolactinomas: a case series of 26 patients. (Pubmed Central) -  Jul 30, 2022   
    Resistant prolactinomas usually require a multi-modal treatment strategy. We were able to control 14/25 (56%) of resistant tumors.
  • ||||||||||  cabergoline / Generic mfg.
    Journal:  Doppler ultrasonographic evaluation of medically treated female dogs with cystic endometrial hyperplasia-pyometra complex. (Pubmed Central) -  Jul 27, 2022   
    Twelve diestrous female dogs suffering from CEH-P were treated with a combined protocol of cabergoline, cloprostenol, and antibiotics...Although comparisons of PSV, EDV, and NDI were significantly different, these results should be cautiously interpreted due to the low statistical power. female dogs that responded to this treatment showed an increase in uterine artery resistance, along with clinical and ultrasonographic improvement.
  • ||||||||||  cabergoline / Generic mfg.
    Unusual Complication after a controlled ovarian stimulation presenting as ascites () -  Jul 16, 2022 - Abstract #ENDO2022ENDO_2342;    
    Ovarian hyperstimulation syndrome (OHSS) is the most serious complication of controlled ovarian hyperstimulation (COH) for assisted reproduction technologies (ART). Hereby we are describing the case of a patient who developed severe OHSS presenting prominent ascites who benefitted from early onset cabergoline therapy and paracentesis.
  • ||||||||||  cabergoline / Generic mfg.
    Treating human primary non-functioning pituitary adenoma cells with cabergoline () -  Jul 16, 2022 - Abstract #ENDO2022ENDO_2316;    
    Our data suggest that the difference in cabergoline responses between NFPAs and prolactinomas may be due to their distinct expression of D2DR isoforms, ultimately leading to the contrasting viability results after cabergoline treatment. Taken together, these data will help inform future treatment strategies for patients with NFPAs.
  • ||||||||||  cabergoline / Generic mfg., thyroxine / Generic mfg.
    Pituitary apoplexy presenting as left basal ganglia hemorrhage () -  Jul 16, 2022 - Abstract #ENDO2022ENDO_2016;    
    Patient underwent tracheostomy and gastrostomy tube placement and was discharged to long term acute care facility. He continued his neurological recovery and was later weaned off the ventilator and was decannulated.
  • ||||||||||  cabergoline / Generic mfg.
    Cushing's Disease in a Patient Presenting with Hyperprolactinemia – A Lesson to Avoid Premature Closure () -  Jul 16, 2022 - Abstract #ENDO2022ENDO_1359;    
    She was initially thought to have a microprolactinoma and started on cabergoline, but full diagnostic workup revealed Cushing's disease. This patient scenario illustrates the importance of being cognizant of premature closure and anchoring bias, which may contribute to medical error, and the importance of maintaining a broad differential especially when patients do not respond to the initial treatment.
  • ||||||||||  progesterone / Generic mfg., cabergoline / Generic mfg.
    Preclinical, Journal:  The elusive role of prolactin in the sociality of the naked mole-rat. (Pubmed Central) -  Jul 9, 2022   
    Furthermore, females receiving Cabergoline did not show any behavioural or hormonal (progesterone) differences, and urinary prolactin did not appear to be suppressed in individuals receiving Cabergoline. While the results add to the relatively limited literature experimentally manipulating prolactin to investigate its role in reproduction and behaviour, they fail to explain why prolactin levels are high in non-breeding naked mole-rats, or how female non-breeding phenotypes are maintained.
  • ||||||||||  cabergoline / Generic mfg.
    Enrollment closed:  LISTA: Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss (clinicaltrials.gov) -  Jul 8, 2022   
    P2,  N=73, Active, not recruiting, 
    While the results add to the relatively limited literature experimentally manipulating prolactin to investigate its role in reproduction and behaviour, they fail to explain why prolactin levels are high in non-breeding naked mole-rats, or how female non-breeding phenotypes are maintained. Recruiting --> Active, not recruiting
  • ||||||||||  cabergoline / Generic mfg., bromocriptine / Generic mfg.
    Review, Journal:  Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus. (Pubmed Central) -  Jun 29, 2022   
    Indeed, bromocriptine is a novel therapy for T2DM patients, as its mechanism of action is unique in T2DM patients with minimal adverse effects. This review summarizes the potential of dopamine agonists in the treatment of T2DM.
  • ||||||||||  cabergoline / Generic mfg.
    Journal:  Ectopic Cavernous Sinus Microprolactinoma Treated Medically. (Pubmed Central) -  Jun 28, 2022   
    We present a case of ectopic dopamine-resistant microprolactinoma treated with cabergoline which led to symptom resolution, hormonal remission, and cystic degeneration of the tumor...These are achieved through primarily medical management or surgery. Even though ectopic microprolactinomas are still frequently addressed surgically, this case shows that medical therapy can successfully treat ectopic prolactin-secreting pituitary microadenomas even in cases of dopamine resistance.
  • ||||||||||  cabergoline / Generic mfg., everolimus / Generic mfg.
    Journal:  DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells. (Pubmed Central) -  Jun 22, 2022   
    In conclusion, this study revealed that cabergoline might overcome the everolimus escape mechanism in NF-PitNETs and tumoral lactotrophs by inhibiting upstream AKT activation. The co-administration of cabergoline might improve mTOR inhibitor antitumoral activity, paving the way for a potential combined therapy in β-arrestin 2-expressing NF-PitNETs or other PitNETs resistant to conventional treatments.
  • ||||||||||  cabergoline / Generic mfg.
    Review, Journal:  The dopaminergic control of Cushing's syndrome. (Pubmed Central) -  Jun 14, 2022   
    Dopamine agonists (DAs), particularly cabergoline (CAB), are currently used as off-label treatment for CD, the most common form of CS, demonstrating efficacy in controlling hormone secretion and tumour growth in a relevant number of cases, with the improvement of clinical picture, and displaying good safety profile...A certain beneficial effect of CAB has been also reported in ectopic CS. However, the role of DAs in the clinical management of the different types of CS requires further evaluations.
  • ||||||||||  cabergoline / Generic mfg., baclofen / Generic mfg.
    Journal:  Type 1 neurodegeneration with brain iron accumulation: a case report. (Pubmed Central) -  Jun 8, 2022   
    Both dopamine agonists and anticholinergic agents are useful to treat motor symptoms, but there is not yet an effective treatment to stop the underlying degeneration. New therapeutic approaches are needed to counteract late stages of the disease and improve prognosis.
  • ||||||||||  cabergoline / Generic mfg.
    Journal:  Mild hyperprolactinemia in a couple: what impact on fertility? (Pubmed Central) -  Jun 4, 2022   
    Preference is given to cabergoline at the lowest possible dose that normalizes PRL, restoring fertility in the vast majority of cases...However, more clinical studies are clearly needed concerning male reproductive function. The significance of mild but persistent hyperprolactinemia in either member of a couple incidentally discovered during assisted reproductive technology (ART) procedures is unclear, and future evidence-based studies are needed to determine whether normalizing prolactin can improve ART outcome.
  • ||||||||||  cabergoline / Generic mfg.
    Review, Journal:  A rare case of a giant prolactinoma with atypical histological features: 5 years of follow-up. (Pubmed Central) -  May 29, 2022   
    The significance of mild but persistent hyperprolactinemia in either member of a couple incidentally discovered during assisted reproductive technology (ART) procedures is unclear, and future evidence-based studies are needed to determine whether normalizing prolactin can improve ART outcome. Giant prolactinomas presenting with multiple pituitary hormone deficiencies in childhood or adolescence are rare and require prompt diagnosis and multidisciplinary management.
  • ||||||||||  cabergoline / Generic mfg., bromocriptine / Generic mfg.
    Retrospective data, Journal:  Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas. (Pubmed Central) -  May 18, 2022   
    The use of DA as a first-line treatment for at least one month before deciding on surgery is recommended in giant and macro-prolactinomas with VFD. Surgery should be considered only in cases with DA resistance or persistent visual impairment despite medical therapy.
  • ||||||||||  cabergoline / Generic mfg.
    Journal:  Quantitative Evaluation of Pupil Responses in Patients with Prolactinomas Being Treated with Dopamine Agonists. (Pubmed Central) -  May 17, 2022   
    The aim of this study was to determine whether the dopamine agonist (DA) drug cabergoline used in the treatment of prolactinoma causes autonomic dysfunction by measuring static and dynamic pupillary responses...DA drug use changes static and dynamic pupillary responses, probably by increasing sympathetic tone. Pupillometry can be used as a non-invasive method to provide information about changes in the autonomic nervous system in patients receiving such drug therapy.